|
Monthly newsletter December 2016 |
|
Adriano Henney's farewell messageAfter having covered the role of Executive Director of the VPHi for two years, Adriano will leave the directorship of the Institute in the hands of Prof Lies Geris to coordinate the Avicenna Alliance more closely. Read more |
|
|
|
|
Contribute to the Avicenna Alliance: join a working group as a VPHi expertCatch the opportunity to collaborate with the new Association for Predictive Medicine, elbow-to-elbow with the top industries in the field.
|
|
Revising the guidelines on first in-human clinical trials Read more |
|
Horizon 2020 attracts ever more interest, report shows Read more |
|
|
Maltese Presidency of the Council – priorities Read more |
| EC announces the members of the new High Level Group on vision for future EU research and innovation Read more |
| Members of renewed Expert Panel on Health appointed Read more |
| EU takes new actions to help close the gap in Research Excellence across Europe |
| Public consultation on strengthening EU cooperation on Health Technology Assessment (HTA)- open Read more |
| UK Government to spend £4.745B on R&D as a Post-Brexit Boost Read more |
| Tina Morrison from FDA visits VPHi member KU Leuven Read more
|
| | | |
Nature publishes an editorial on the power of big data for medical progress Read more |
|
In silico modeling at NASA Ames workshop on vascular tissue challenge Read more |
|
Prof Jerome Noailly appointed Chair of the VPHi Student Committee Read more |
|
...more on the VPHi board: This year the SBI director, Prof Walter Kolch, was elected to the membership of the Royal Irish Academy, the highest academic honour in Ireland
|
|
|
|
|
|
|
| |
IDIBAPS in Barcelona is seeking for a highly motivated PhD student for Personalizing health care in Multiple Sclerosis using systems medicine tools Read more |
| University of California hires to build a group in mathematical modeling of complex biosystems Read more |
| | | | | |
ARE YOU NOT A MEMBER OF THE VPH INSTITUTE YET? We need your support to ensure that the VPH is fully realised, universally adopted, and effectively used both in research and clinic.
|
| |
|
